Contract 75N90025P00194
Quva Pharma, Inc. · Department Of Health And Human Services · July 9, 2025
Quva Pharma, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 9, 2025 for $100,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Sugar Land, TX. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $100,000.
Contract details
- PIID
- 75N90025P00194
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Sugar Land, TX
- First action
- July 9, 2025
Description
PHARMACEUTICALS QUVA PHARMA, INC.:1327585 [25-000116]
Modification timeline
-
July 9, 2025Mod P00001 · Other Administrative Action$100.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N90025P00194?
Contract 75N90025P00194 is a federal contract awarded to Quva Pharma, Inc. by Department Of Health And Human Services on July 9, 2025 for $100,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N90025P00194?
Quva Pharma, Inc. won contract 75N90025P00194 from Department Of Health And Human Services.
How much is contract 75N90025P00194 worth?
Contract 75N90025P00194 has obligated $0 to date but carries a potential ceiling of $100,000 if fully funded and all options are exercised.